| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Combination therapy with nilotinib for drug-sensitive and drug-resistant BCR-ABL-positive leukemia and other malignancies
|
Weisberg, Ellen
|
|
2014
|
88 |
12 |
p. 2233-2242
|
article
|
| 2 |
Commentary to Pastore et al. (2014): Epidermal growth factor receptor signaling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
|
Takeda, Kozue
|
|
2014
|
88 |
12 |
p. 2319-2320
|
article
|
| 3 |
Current developments in nanosafety research
|
Hammad, Seddik
|
|
2014
|
88 |
12 |
p. 2089-2091
|
article
|
| 4 |
Current developments in toxicology
|
Bolt, Hermann M.
|
|
2014
|
88 |
12 |
p. 2093-2095
|
article
|
| 5 |
Current research on cell death mechanisms
|
Bolt, Hermann M.
|
|
2014
|
88 |
12 |
p. 2079-2082
|
article
|
| 6 |
Facilitating a transparent and tailored scientific discussion about the added value of animal feeding trials as well as in vitro and in silico approaches with whole food/feed for the risk assessment of genetically modified plants
|
Schiemann, Joachim
|
|
2014
|
88 |
12 |
p. 2067-2069
|
article
|
| 7 |
Grouping of nanomaterials for risk assessment
|
Bolt, Hermann M.
|
|
2014
|
88 |
12 |
p. 2077-2078
|
article
|
| 8 |
In vitro systems: current limitations and future perspectives
|
Ghallab, Ahmed
|
|
2014
|
88 |
12 |
p. 2085-2087
|
article
|
| 9 |
Manufactured nanomaterials: categorization and approaches to hazard assessment
|
Gebel, Thomas
|
|
2014
|
88 |
12 |
p. 2191-2211
|
article
|
| 10 |
Ninety-day oral toxicity studies on two genetically modified maize MON810 varieties in Wistar Han RCC rats (EU 7th Framework Programme project GRACE)
|
Zeljenková, Dagmar
|
|
2014
|
88 |
12 |
p. 2289-2314
|
article
|
| 11 |
Replica to K. Takeda et al. Commentary to Pastore et al. (2014): Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
|
Pastore, Saveria
|
|
2014
|
88 |
12 |
p. 2321-2322
|
article
|
| 12 |
Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease
|
Lim, Keng Gat
|
|
2014
|
88 |
12 |
p. 2213-2232
|
article
|
| 13 |
Reviews on cutting-edge topics in toxicology
|
Bolt, Hermann M.
|
|
2014
|
88 |
12 |
p. 2097
|
article
|
| 14 |
Safety limits for elements in toys: a comparison between the old and the new European toys safety directive
|
Vieth, Bärbel
|
|
2014
|
88 |
12 |
p. 2315-2318
|
article
|
| 15 |
SEURAT-1 liver gold reference compounds: a mechanism-based review
|
Jennings, Paul
|
|
2014
|
88 |
12 |
p. 2099-2133
|
article
|
| 16 |
Standard compounds for establishment of in vitro test systems
|
Hengstler, J. G.
|
|
2014
|
88 |
12 |
p. 2083-2084
|
article
|
| 17 |
The virtual liver: state of the art and future perspectives
|
Drasdo, Dirk
|
|
2014
|
88 |
12 |
p. 2071-2075
|
article
|
| 18 |
Toxicogenomics directory of chemically exposed human hepatocytes
|
Grinberg, Marianna
|
|
2014
|
88 |
12 |
p. 2261-2287
|
article
|
| 19 |
Toxicogenomics directory of chemically exposed human hepatocytes
|
Grinberg, Marianna
|
|
|
88 |
12 |
p. 2261-2287
|
article
|
| 20 |
U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells
|
Smutny, Tomas
|
|
2014
|
88 |
12 |
p. 2243-2259
|
article
|
| 21 |
Workshop report: Identifying opportunities for global integration of toxicogenomics databases, 26–27 June 2013, Research Triangle Park, NC, USA
|
Hendrickx, Diana M.
|
|
2014
|
88 |
12 |
p. 2323-2332
|
article
|
| 22 |
Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
|
Oesch, F.
|
|
2014
|
88 |
12 |
p. 2135-2190
|
article
|
Journal description